Cellect Biotechnology Ltd.

6.00+0.2400+4.17%Vol 107.57K1Y Perf 186.25%
Sep 23rd, 2021 13:44 DELAYED
BID6.01 ASK6.04
Open5.75 Previous Close5.76
Pre-Market- After-Market-
 - -%  - -
Target Price
12.00 
Analyst Rating
— 0.00
Potential %
100.00 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
60.17 
Earnings Rating
Neutral
Market Cap23.45M 
Earnings Date
25th Aug 2021
Alpha-0.02 Standard Deviation0.25
Beta1.86 

Today's Price Range

5.756.04

52W Range

1.658.88

5 Year PE Ratio Range

-3.40-3.00

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
-9.15%
1 Month
34.89%
3 Months
53.19%
6 Months
57.81%
1 Year
186.25%
3 Years
-77.05%
5 Years
-74.57%
10 Years
-

TickerPriceChg.Chg.%
APOP6.000.24004.17
AAPL146.921.07000.73
GOOG2 842.2123.44000.83
MSFT300.121.54000.52
XOM57.041.83003.31
WFC48.030.95002.02
JNJ165.521.59000.97
FB346.623.41000.99
GE103.775.23005.31
JPM161.515.60003.59
Earnings HistoryEstimateReportedSurprise %
Q03 2020--0.12-
Q02 2020--0.69-
Q01 2020--0.22-
Q04 2019--0.77-
Q03 2019--0.61-
Q02 2019--0.02-
Q01 2019--0.16-
Q04 2018--0.16-
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.36-24.14Negative
12/2018 FY-1.07-9.18Negative
3/2019 QR-0.33-6.45Negative
12/2019 FY-1.228.27Positive
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume107.57K
Shares Outstanding3.91M
Shares Float3.92M
Trades Count619
Dollar Volume441.23K
Avg. Volume1.92M
Avg. Weekly Volume311.88K
Avg. Monthly Volume4.86M
Avg. Quarterly Volume1.92M

Cellect Biotechnology Ltd. (NASDAQ: APOP) stock closed at 5.76 per share at the end of the most recent trading day (a -4% change compared to the prior day closing price) with a volume of 221.29K shares and market capitalization of 23.45M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 14 people. Cellect Biotechnology Ltd. CEO is Shai Yarkoni.

The one-year performance of Cellect Biotechnology Ltd. stock is 186.25%, while year-to-date (YTD) performance is 166.67%. APOP stock has a five-year performance of -74.57%. Its 52-week range is between 1.65 and 8.88, which gives APOP stock a 52-week price range ratio of 60.17%

Cellect Biotechnology Ltd. currently has a PE ratio of -5.10, a price-to-book (PB) ratio of 14.72, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -84.39%, a ROC of -114.11% and a ROE of -120.92%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Cellect Biotechnology Ltd., there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Cellect Biotechnology Ltd.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Cellect Biotechnology Ltd. is (0), with a target price of $12, which is +100.00% compared to the current price. The earnings rating for Cellect Biotechnology Ltd. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Cellect Biotechnology Ltd. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Cellect Biotechnology Ltd. has a Buy technical analysis rating based on Technical Indicators (ADX : 22.08, ATR14 : 0.59, CCI20 : 11.41, Chaikin Money Flow : -0.39, MACD : 0.44, Money Flow Index : 92.70, ROC : -13.90, RSI : 53.48, STOCH (14,3) : 18.32, STOCH RSI : 0.00, UO : 44.02, Williams %R : -81.68), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Cellect Biotechnology Ltd. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Summary Rating--Strong Buy
1.00

Cellect Biotechnology Ltd.

Cellect Biotechnology Ltd is a biotechnology company that has developed a novel technology platform known as ApoGraft that functionally selects cells in order to improve the safety and efficacy of regenerative medicine and cell therapies. The company is developing its first product based on its ApoGraft technology platform, the ApoTainer kit that utilizes FasL- apoptotic protein.

CEO: Shai Yarkoni

Telephone: +972 99741444

Address: 23 Hata'as Street, Kfar Saba 44425, , IL

Number of employees: 14

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

100%0%

Bearish Bullish

64%36%

Bearish Bullish

51%49%

News

Stocktwits